Izabella Valdez

Izabella Valdez

Auto-generated profile, based on publicly available information

Izabella Valdez

Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 1

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SEShlomo Elias
Shlomo Elias
RSRahul Sharma
Rahul Sharma
MSMichael Schizas
Michael Schizas
IVIzabella Valdez
Izabella Valdez
SRSham Rampersaud
Sham Rampersaud
ARAlexander Y. Rudensky
Alexander Y. Rudensky
Regulatory T (Treg) cells represent a specialized lineage of suppressive CD4+ T cells whose functionality is critically dependent on their ability to migrate to and dwell in the proximity of cells they control. Here we show that continuous expression of the chemokine receptor CXCR4 in Treg cells is required for their ability to accumulate in the bone marrow (BM). Induced CXCR4 ablation in Treg cells led to their rapid depletion and consequent increase in mature B cells, foremost the B-1 subset, observed exclusively in the BM without detectable changes in plasma cells or hematopoietic stem cells or any signs of systemic or local immune activation elsewhere. Dysregulation of BM B-1 B cells was associated with a highly specific increase in IgM autoantibodies and total serum IgM levels. Thus, Treg cells control autoreactive B-1 B cells in a CXCR4-dependent manner. These findings have significant implications for understanding the regulation of B cell autoreactivity and malignancies.